Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and Other Liabilities (Details)

v3.21.2
Accrued expenses and Other Liabilities (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Accrued Expenses and Other Liabilities    
Accrued clinical trial expenses $ 529,482 $ 628,000
Accrued manufacturing expenses 174,174 175,089
Compensation and related benefits 458,914 209,600
Accrued franchise tax 147,500 172,500
Other expenses 350,218 429,345
Accrued expenses $ 1,660,288 $ 1,614,534